The Risk Comparison Between Large Enterprises and SMEs on Chinese Pharmaceutical Industry

The development of Medium and small enterprises (SMEs) in China are facing many difficulties to overcome its economic contradictions and problems. Financing will bear the brunt. As the SME's own characteristics, which is small and the controllable resources are scarcer, often are growing rapidly, and require large capital investments. The current situation of SME financing is not good. The paper contributes using the basic method of statistical analysis of variance according to the research on financing difficulties of SMEs in relation to their business risks. Firstly the solvency indexes reflect the businesses are illustrated. Secondly, the paper introduces the basic principles of variance analysis and homogeneity of variance test and variance analysis of multiple comparisons. Finally the use of SPASS on the pharmaceutical industries' solvency targets is analysed through the financial indicators related to SMEs' finance difficult situation verified whether the risk of their operations has a significant impact. Keywords: SMEs; finance difficulty; operation risk; variance analysis; solvency ability. Resume: Le developpement des petites et moyennes entreprises (PME) en Chine est en train de faire face a de nombreuses difficultes pour surmonter les contradictions et les problemes economiques. Le financement fera les frais. Comme les caracteristiques propres des PME, elles sont petites, leurs ressources controlables sont plus rares, elles ont une croissance de plus en plus rapide et ont besoin de gros investissements. La situation actuelle du financement des PME n'est pas tres bonne. Le present article utilise une methode de base de l'analyse statistique de la variance en fonction de la recherche sur les difficultes de financement des PME par rapport a leurs risques d'affaires. Tout